ATNF logo

180 Life Sciences (ATNF)

Profile

Full Name

180 Life Sciences Corp.

Ticker Symbol

ATNF

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 27, 2017

Indexes

Not included

Website

http://180lifesciences.com

Employees

4

Key Details

Price

$0.90(+2.51%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$15.49(+70.55% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.90
ATNF price is $0.90

30-Day Relative Volume

0.20
ATNF 30-day relative volume is 0.20

Price Performance

Price Most recent change

+2.51%
ATNF price was up +2.51% on Apr 17, 2025

Price YTD change

-50.6%
ATNF price is down -50.6% since January 1st

Price 1-year change

-52.93%
ATNF price is down -52.93% year-on-year

Price 3-year change

-99.88%
ATNF price is down -99.88% over the past 3 years

Price Range

Price All-time high

$4957.10
ATNF price is currently -99.98% below its historical high of $4957.10

Price 3-year low

$0.66
ATNF price is currently +36.63% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.48M
ATNF market capitalization is $3.48 million

Market cap 3-year change

-94.8%
ATNF market capitalization is down -94.8% over the past 3 years

Market cap All-time high

$366.01M
ATNF market capitalization is currently -99.05% below its historical high of $366.01 million

Market cap sector rank

9.71%
ATNF market capitalization is higher than 9.71% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+353.54%
ATNF shares outstanding is up +353.54% year-on-year

Shares Outstanding 3-Year Change

+4211.93%
ATNF shares outstanding is up +4211.93% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.26
ATNF beta is 1.26

200-day SMA

$1.91
ATNF price is currently -52.93% below its 200-day simple moving average

50-day SMA

$1.10
ATNF price is currently -18.49% below its 50-day simple moving average

RSI

44.34
ATNF 14-day relative strength index is 44.34

Volume

0.20
ATNF 30-day relative volume is 0.20

ATR

$0.11
ATNF average true range is $0.11

10-day Historical Volatility

143.80%
ATNF 10-day historical volatility is 143.80%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ATNF annual revenue value is unknown

Revenue Analysts estimate

$16.64M
ATNF annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
ATNF annual revenue 1-year change is unknown

Revenue Sector rank

-
ATNF annual revenue is unknown

EPS

EPS

-$15.49
ATNF annual earnings per share is -$15.49

EPS Analysts estimate

-
ATNF annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+70.55%
ATNF annual earnings per share is up +70.55% year-on-year

EPS Sector rank

8.78%
ATNF annual earnings per share is higher than 8.78% of companies in Healthcare sector

Profit

Gross profit

-
ATNF annual gross profit value is unknown

Gross margin

-
ATNF annual gross profit margin value is unknown

Operating profit

-$6.32M
ATNF annual operating income is -$6.32 million

Operating margin

-
ATNF annual operating profit margin value is unknown

Net income

-$6.17M
ATNF annual net profit is -$6.17 million

Net margin

-
ATNF annual net profit margin value is unknown

Expenses

Total expenses

$6.32M
ATNF annual total expenses is $6.32 million

Operating expenses

$6.32M
ATNF annual total operating expenses is $6.32 million

Cost of goods sold

-
ATNF annual cost of goods sold value is unknown

Selling, general & administrative expenses

$4.36M
ATNF annual SGA is $4.36 million

Depreciation and amortization

$58.30K
ATNF annual depreciation & amortization is $58.30 thousand

Interest expense

$50.60K
ATNF annual interest expense is $50.60 thousand

Income tax

-$296.00K
ATNF annual income tax is -$296.00 thousand

EBIT & EBITDA

EBIT

-$6.41M
ATNF annual earnings before interest & taxes is -$6.41 million

EBITDA

-$6.36M
ATNF annual EBITDA is -$6.36 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$12.76M
ATNF annual total assets is $12.76 million

Non current assets

$7.62M
ATNF annual long term assets is $7.62 million

Current assets

$5.14M
ATNF annual total current assets is $5.14 million

Cash and cash equivalents

$4.59M
ATNF annual cash & cash equivalents is $4.59 million

Accounts receivable

-
ATNF annual accounts receivable value is unknown

Inventory

-
ATNF annual inventory value is unknown

Liabilities

Total liabilities

$3.51M
ATNF annual total liabilities is $3.51 million

Long term liabilities

$6600.00
ATNF annual total long term liabilities is $6600.00

Current liabilities

$3.50M
ATNF annual total current liabilities is $3.50 million

Accounts payable

$1.93M
ATNF annual accounts payable is $1.93 million

Debt

Total debt

$154.50K
ATNF annual total debt is $154.50 thousand

Total debt 1-year change

-85.34%
ATNF annual total debt is down -85.34% year-on-year

Long term debt

$6600.00
ATNF annual long term debt is $6600.00

Short term debt

$147.90K
ATNF annual short term debt is $147.90 thousand

Equity & Capital

Shareholders equity

$9.25M
ATNF annual stockholders equity is $9.25 million

Book value

$9.25M
ATNF annual book value is $9.25 million

Retained earnings

-$141.52M
ATNF annual retained earnings is -$141.52 million

Working capital

$1.64M
ATNF annual working capital is $1.64 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$1.48M
ATNF annual cash flow from operations is -$1.48 million

Cash from operations 1-year change

+86.44%
ATNF annual cash flow from operations is up +86.44% year-on-year

Cash from investing

-
ATNF annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
ATNF annual cash flow from investing activities 1-year change is unknown

Cash from financing

$4.04M
ATNF annual cash flow from financing activities is $4.04 million

Cash from financing 1-year change

-31.66%
ATNF annual cash flow from financing activities is down -31.66% year-on-year

CAPEX

CAPEX

-
ATNF annual capital expenditures value is unknown

CAPEX 1-year change

-
ATNF annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$1.48M
ATNF annual free cash flow is -$1.48 million

Free cash flow 1-year change

+86.44%
ATNF annual free cash flow is up +86.44% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ATNF annual gross profit margin value is unknown

Operating margin

-
ATNF annual operating profit margin value is unknown

Net margin

-
ATNF annual net profit margin value is unknown

ROA & ROE

ROA

-48.33%
ATNF annual return on assets is -48.33%

ROE

-66.67%
ATNF annual return on equity is -66.67%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ATNF price to earnings ratio value is unknown

PE ratio Sector rank

-
ATNF price to earnings ratio is unknown

PB Ratio

PB ratio

0.38
ATNF price to book ratio is 0.38

PB ratio Sector rank

26.22%
ATNF price to book ratio is higher than 26.22% of companies in Healthcare sector

PS Ratio

PS ratio

-
ATNF price to sales ratio value is unknown

PS ratio Sector rank

-
ATNF price to sales ratio is unknown

Enterprise value

Enterprise value

-$953.45K
ATNF enterprise value is -$953.45 thousand

Enterprise value Sector rank

10.17%
ATNF enterprise value is higher than 10.17% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.15
ATNF EV/EBITDA is 0.15

EV/EBITDA Sector rank

68.49%
ATNF EV/EBITDA is higher than 68.49% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.47
ATNF annual current ratio is 1.47

Quick ratio

-
ATNF annual quick ratio value is unknown

Leverage

Debt to equity

0.02
ATNF annual debt to equity ratio is 0.02

Interest coverage ratio

-126.75
ATNF annual interest coverage ratio is -126.75

Risk & Stability

Piotroski F-Score

-
ATNF piotroski f-score value is unknown

Altman Z-Score

-
ATNF altman z-score value is unknown

Analyst ratings

Recent major analysts updates

May 9, 22 Maxim Group
Hold
Sep 15, 21 Maxim Group
Buy

Institutional Ownership

Similar stocks

NBY logo
NovaBay Pharmaceuticals (NBY)
RSLS logo
ReShape Lifesciences (RSLS)
TTNP logo
Titan Pharmaceuticals (TTNP)
HSCS logo
Heart Test Laboratories (HSCS)
XRTX logo
XORTX Therapeutics (XRTX)
JAGX logo
Jaguar Health (JAGX)
XYLO logo
Xylo Technologies (XYLO)
PALI logo
Palisade Bio (PALI)
MBIO logo
Mustang Bio (MBIO)
  • What is the ticker symbol for 180 Life Sciences?
  • Does 180 Life Sciences pay dividends?
  • What sector is 180 Life Sciences in?
  • What industry is 180 Life Sciences in?
  • What country is 180 Life Sciences based in?
  • When did 180 Life Sciences go public?
  • Is 180 Life Sciences in the S&P 500?
  • Is 180 Life Sciences in the NASDAQ 100?
  • Is 180 Life Sciences in the Dow Jones?
  • When was 180 Life Sciences's last earnings report?
  • When does 180 Life Sciences report earnings?
  • Should I buy 180 Life Sciences stock now?

What is the ticker symbol for 180 Life Sciences?

The ticker symbol for 180 Life Sciences is NASDAQ:ATNF

Does 180 Life Sciences pay dividends?

No, 180 Life Sciences does not pay dividends

What sector is 180 Life Sciences in?

180 Life Sciences is in the Healthcare sector

What industry is 180 Life Sciences in?

180 Life Sciences is in the Biotechnology industry

What country is 180 Life Sciences based in?

180 Life Sciences is headquartered in United States

When did 180 Life Sciences go public?

180 Life Sciences's initial public offering (IPO) was on June 27, 2017

Is 180 Life Sciences in the S&P 500?

No, 180 Life Sciences is not included in the S&P 500 index

Is 180 Life Sciences in the NASDAQ 100?

No, 180 Life Sciences is not included in the NASDAQ 100 index

Is 180 Life Sciences in the Dow Jones?

No, 180 Life Sciences is not included in the Dow Jones index

When was 180 Life Sciences's last earnings report?

180 Life Sciences's most recent earnings report was on Nov 14, 2024

When does 180 Life Sciences report earnings?

The next expected earnings date for 180 Life Sciences is May 15, 2025

Should I buy 180 Life Sciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page